ByTrending Posts
Pfizer Expands Deal to $610M, AI Drug Discovery…
Boston – Jan 7, 2025 Strengthening AI-Driven Innovation in Small Molecules and ADCs Pfizer has expanded its partnership…
Terray’s AI-Driven Drug Discovery Platform Secures Collaboration with…
Boston – Dec 17, 2024 Strategic Expansion Following $120M Series B Terray Therapeutics is closing the year with…
Unlearn AI’s Breakthroughs in AI-Driven Clinical Development: 2024…
San Francisco – December 12, 2024 Unlearn AI has emerged as a leader in AI-powered clinical trial innovation,…
How Unlearn AI Is Increasing the Efficiency of…
December 11, 2024 Enhanced TwinRCT™ 3.0 Unlearn® has introduced an upgraded version of its AI-driven TwinRCT™ solution—TwinRCT 3.0,…
Relation Therapeutics, NVIDIA-Backed AI-Biotech, and GSK Announce Strategic…
London, UK – December 10, 2024 Relation, a leader in computational and experimental drug discovery, has announced two…
Recursion Reports Promising Interim Data for AI-Designed CDK7…
Salt Lake City – December 9, 2024 Recursion (Nasdaq: RXRX), a leader in AI-powered drug discovery, has released…
Recursion Doses First Patient in Phase 1/2 Trial…
Recursion (NASDAQ: RXRX), a cutting-edge clinical-stage TechBio company, has announced the successful dosing of the first patient in…
AI Drug Discovery Leaders Recursion and Exscientia Merge…
Recursion and Exscientia, two trailblazers in AI-driven drug discovery, have officially merged to form a technology-powered platform aimed…
NVIDIA Expands AI-Driven Drug Discovery with BioNeMo Framework
November 18, 2024 NVIDIA has launched a major initiative to scale AI-powered drug discovery through the open-source BioNeMo…
Trending Posts
Latest Stories
Is Lilly Shaping Its Post-Blockbuster Future Through Verve, Superluminal, and AI-Driven Partnerships in 2025?
In 2025, Eli Lilly and Company approached dealmaking from a position of strength. With blockbuster…
Is Lilly Strengthening Its 2026 Growth Outlook by Scaling Zepbound, Mounjaro, and Its Core Innovation Engine in 2025?
In 2025, Eli Lilly and Company continued to build on its strong momentum, executing a…
Pfizer’s Strategic Deals in 2025: Key Moves Shaping the Company’s Next Phase
Strategic Takeaways In 2025, Pfizer executed a series of focused and strategic deals aimed at…
Can Pfizer’s 2025 Execution Set the Stage for Sustainable Growth in 2026?
NEW YORK, NY — As 2025 comes to a close, Pfizer Inc. reflects on a…
Gallery
